CAV1 and hepatocellular carcinoma: These studies indicated that in HCC cell lines, CAV1 protects against TGF-β-induced apoptosis by EGF receptor transactivation and PI3K/Akt signaling while reducing NADPH oxidase and pro-apoptotic BMF transcription (Moreno-Càceres et al., 2017).